We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
MgO-enhanced β-TCP promotes osteogenesis in both in vitro and in vivo rat models.
- Authors
Saito, Kenichiro; Inagaki, Yusuke; Uchihara, Yoshinobu; Okamoto, Masakazu; Nishimura, Yuki; Kawai, Akihito; Sugino, Tatsuro; Okamura, Kensuke; Ogawa, Munehiro; Kido, Akira; Tanaka, Yasuhito
- Abstract
Allogeneic bone grafts are used to treat bone defects in orthopedic surgery, but the osteogenic potential of artificial bones remains a challenge. In this study, we developed a β-tricalcium phosphate (β-TCP) formulation containing MgO, ZnO, SrO, and SiO2 and compared its bone-forming ability with that of β-TCP without biological elements. We prepared β-TCP discs with 60% porosity containing 1.0 wt% of these biological elements. β-TCP scaffolds were loaded with bone marrow-derived mesenchymal stem cells (BMSC) from 7-week-old male rats and cultured for 2 weeks. ALP activity and mRNA expression of osteogenic markers were evaluated. In addition, scaffolds were implanted subcutaneously in rats and analyzed after 7 weeks. In vitro, the MgO group showed lower Ca concentrations and higher osteogenic marker expression compared to controls. In vivo, the MgO group showed higher ALP activity compared to controls, and RT-qPCR analysis showed significant expression of BMP2 and VEGF. Histopathology, fluorescent immunostaining, and micro-CT also showed relatively better bone formation in the MgO group. β-TCP with MgO may enhance bone morphology in vitro and in vivo and improve the prognosis of patients with substantial and refractory bone defects.
- Subjects
LABORATORY rats; BONE regeneration; BONE growth; MESENCHYMAL stem cells; ARTIFICIAL bones; ORTHOPEDIC surgery; GENE expression
- Publication
Scientific Reports, 2024, Vol 14, Issue 1, p1
- ISSN
2045-2322
- Publication type
Article
- DOI
10.1038/s41598-024-70512-5